The Global Image Guided Systems Market was valued at US$ 7.23 Billion in 2022 and is expected to reach US$ 17.41 Billion by 2033. The devices segment with a market share more than 75% has topped the global market within the product category and is expected to grow at a CAGR of close to 8.2% over the forecast period (2023 to 2033).
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 7.23 Billion |
| Market Value 2023 | US$ 7.79 Billion |
| Market Value 2033 | US$ 17.41 Billion |
| CAGR 2023 to 2033 | 8.4% |
| Share of Top 5 Countries | 63.4% |
| Key Players | Siemens Healthineers; Analogic Corporation; GE Healthcare; Koninklijke Philips N.V.; Stryker Corporation; Carestream Health; Hitachi Medical Corporation; Hologic; United Imaging Technologies Inc.; BrainLab AG; Karl Storz Gmbh & Co. Kg; Smith & Nephew Plc; Esaote SpA; Zimmer Biomet; Varian Medical Systems; Inc.; Medtronic Plc.; EndoMed Systems; Maxer Endoscopy; Blazejewski MEDI-TECH GmbH; Olympus Corporation; FUJIFILM Holdings Corporation; Shenyang Shenda Endoscope Co.; Ltd.; Shimadzu Corporation; Shenzhen Anke High-tech Co.; Ltd. |
Image guided surgery (IGS) refers to the application of a real-time correlation of the surgical field to a preoperative imaging data collection that reflects the precise placement of a chosen surgical instrument to the adjacent anatomic structures. Since the development of the endoscopic approach in the middle of the 1980s, image guided surgery has been one of the most important developments in endoscopic approach surgery.
Conventional surgical techniques take longer, are less precise, and include a risk of injury to neighboring nonsurgical areas. As a result, there is a rising need for surgical methods that are more accurate and quick. The benefits of image guided surgery devices include reduced damage, quicker healing of surgical wounds, and higher levels of accuracy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the image guided systems market grew at a CAGR of 7.7% between 2017 and 2022. Image guided systems market contributes 1.4% revenue share to the global medical device market, which is valued at US$ 512.6 Billion in 2022.
Imaging-guided systems are in demand because they provide physicians and other medical professionals with more accurate and precise information during medical procedures. By using imaging technologies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or X-rays, physicians can visualize the internal organs, tissues, and other structures of the body in real time. The technology can help physicians in various ways such as improved accuracy, reduced risk, and enhanced treatment planning which is accelerating the market growth for image guided systems.
Similarly, as a result of technological advancements, there is a greater demand worldwide for image guided systems. Minimally invasive surgeries provide a much faster recovery period and significantly less scarring than more invasive procedures. The rise in brain illnesses, orthopedic conditions, and trauma injuries is another element influencing the market expansion for image-guided surgical equipment.
Considering this, FMI expects the global market to grow at a CAGR of 8.4% through the forecasted years.
There is a growing preference for minimally invasive procedures over traditional open surgeries due to their advantages, including reduced scarring, shorter hospital stays, faster recovery times, and lower risk of complications. Image guided systems play a crucial role in guiding and monitoring minimally invasive interventions, ensuring precise targeting and safe delivery of treatments. The increasing adoption of minimally invasive procedures propels the demand for image guided systems.
The increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has led to a rise in the demand for precise diagnosis, treatment planning, and minimally invasive interventions. Image guided systems offer improved visualization and guidance during procedures, enabling better disease management and patient outcomes.
The rising incidence of cardiovascular diseases (CVDs) and cancer is boosting market growth. CVDs and cancer are usually acute events that comprise the highest death rate in the world. For instance, the global burden of chronic diseases is escalating, with Cardiovascular Diseases (CVDs) responsible for around 32% of the 17.9 million deaths reported by the World Health Organization (WHO) in 2019.
These drivers collectively contribute to the growth and development of the image guided systems market, creating opportunities for technological advancements, market expansion, and improved patient care.
Principal Consultant
While the demand for imaging-guided systems continues to grow, there are also several market restraints that affect the adoption and growth of these systems.
Imaging-guided systems are often expensive to develop, purchase, and maintain. This high cost can limit their adoption, especially in developing countries with limited healthcare budgets. Moreover, in some regions, healthcare facilities may not have access to advanced imaging technologies, which can limit the adoption and use of imaging guided systems.
Regulations can limit the adoption of imaging guided systems in several ways. The approval process of IGS can be lengthy and complex which limits the adoption of these systems. These regulatory challenges can limit the adoption of imaging-guided systems, but they are necessary to ensure patient safety and to maintain high standards of care. Efforts are underway to streamline regulatory processes and to make imaging-guided systems more accessible and affordable for healthcare facilities.
The USA dominated the global market in 2022 and is expected to register a CAGR of 7.5% during the forecast period.
The expansion of the market is being driven by an increase in traumatic brain injuries (TBI) in the nation. In the USA, the prevalence of TBI tumors is increasing, and surgery is one of the management options for TBIs. The Centres for Disease Control and Prevention estimate that there were 69,473 TBI-related fatalities in 2021 and 223,135 hospitalizations due to TBI in 2019.
The USA has a robust healthcare and medical technology sector that fosters the development and adoption of advanced image guided systems. USA companies invest significantly in research and development, leading to the creation of cutting-edge technologies and products.
Germany dominated the European market for image guided systems and accounted for around 7.1% of the market share in 2022.
The development of endoscopic technology, mergers and acquisitions among major market participants, and the introduction of new products are mostly to influence the rise of the German market for Image guided systems.
For instance, Fujifilm introduced ColoAssist PRO, a real-time endoscopic visualization system, in Germany in November 2021. Also, Erbe Elektromedizia also bought Maxer Endoscopy, a Germany-based company, in April 2021 to expand its presence in this region. Therefore, due to the increase in product acceptance, product launches and acquisitions for the expansion of endoscopy services in Germany are anticipated to fuel market growth.
China accounted for revenue share of 4.7% in the global market at the end of 2022. China is projected to be the most attractive market over the forecast period.
According to a research report titled "Cardiovascular Potential Risk Factor and Disease Mortality in China" released in April 2022, the primary contributor to the cost of healthcare is cardiovascular disease (CVD). Furthermore, due to better clinical outcomes, quick recovery, and overall lower cost of minimally invasive surgeries compared to open surgeries, demand for image guided surgery is rising in the nation.
As a result, it is becoming increasingly apparent that people prefer less invasive surgeries will drive the market of image-guided surgery devices during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The devices segment held a market share of around 75.5% of the global market by the end of 2022.
The aspect which is promoting business growth is the demand for minimally invasive therapies. According to a statewide survey study by Johns Hopkins Medicine, the use of minimally invasive procedures for several common operations can reduce postoperative complications and can also save healthcare costs. As a result of the increased demand for less intrusive image-guided treatments, the market is expected to expand in the near future.
The neurosurgery segment accounted for a revenue share of 29.3% in the global market at the end of 2022.
Neurosurgery involves intricate procedures within the brain and nervous system, requiring a high level of precision. Image guided systems provide real-time visualization and navigation tools that enable surgeons to accurately target and navigate through delicate neural structures. Also, the increasing prevalence of these conditions has led to a higher demand for neurosurgical interventions, driving the growth of the image guided systems market in the neurosurgery segment.
The hospital’s segment accounted for a revenue share of 74.8% in the global market at the end of 2022.
Hospitals provide easy access to treatment alternatives, with many offering technologically advanced Image guided systems for a variety of ailments such as urology and oncology surgeries.
Overall, hospitals provide quick and accessible treatment choices for a wide range of chronic illnesses, making them the most popular segment for these treatments.
Key image guided system market companies are investing substantial resources in new product innovation, providing unique equipment to treat patients, and providing life-sustaining treatment. Some major businesses are acquiring other companies in order to strengthen their global market positions, while others are focusing on product launches.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the image guided systems market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Siemens Healthineers; Analogic Corporation; GE Healthcare; Koninklijke Philips N.V.; Stryker Corporation; Carestream Health; Hitachi Medical Corporation; Hologic; United Imaging Technologies Inc.; BrainLab AG; Karl Storz Gmbh & Co. Kg; Smith & Nephew Plc; Esaote SpA; Zimmer Biomet; Varian Medical Systems, Inc.; Medtronic Plc.; EndoMed Systems; Maxer Endoscopy; Blazejewski MEDI-TECH GmbH; Olympus Corporation; FUJIFILM Holdings Corporation; Shenyang Shenda Endoscope Co., Ltd.; Shimadzu Corporation; Shenzhen Anke High-tech Co., Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to reach US$ 17.41 billion by 2033
The market is projected to record a CAGR of 8.4% through 2033.
Siemens Healthineers, Carestream Health, and Medtronic Plc. are some key players.
The medical imaging segment is leading in the image guided systems market.
Integration of artificial intelligence for image analysis and the use of image guided systems in minimally invasive techniques.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Installed Base Scenario, By Key Countries
4.3. Product Features/ USPs
4.4. PESTEL Analysis
4.5. Porter’s Analysis
4.6. Regulatory Landscape
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.1.4. Global Medical Devices Market (Parent Market Analysis)
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Growing Geriatric Population Rate
5.2.3. Growing use of image-guided surgery equipment
5.2.4. Rising Healthcare Spending
5.2.5. Technological Advancement
5.2.6. Increasing Prevalence of Chronic Diseases
5.2.7. Surge in Minimally Invasive Surgeries
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2023 Market Scenario
7. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Volume (in Units) Analysis, 2017 to 2022
7.2. Current and Future Volume (in Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
10.3.1. Device
10.3.1.1. Computed Tomography (CT) Scanners
10.3.1.2. Ultrasound Systems
10.3.1.3. Magnetic Resonance Imaging (MRI)
10.3.1.4. Endoscopes
10.3.1.5. X-ray Fluoroscopy
10.3.1.6. Positron Emission Tomography (PET)
10.3.1.7. Single Photon Emission Computed Tomography (SPECT)
10.3.2. Software
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Cardiac Surgery
11.3.2. Neurosurgery
11.3.3. Orthopedic Surgery
11.3.4. Gastroenterology
11.3.5. Urology
11.3.6. Oncology Surgery
11.3.7. Others (ENT, Dental, Pulmonary surgery
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Clinics
12.3.4. Research & Academic Institutes
12.4. Market Attractiveness Analysis By Application
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. The USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Country Level Analysis & Forecast
14.5.1. USA Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Application
14.5.1.2.3. By End User
14.5.2. Canada Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By Application
14.5.2.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Brazil Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Application
15.5.1.2.3. By End User
15.5.2. Mexico Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Application
15.5.2.2.3. By End User
15.5.3. Argentina Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By Application
15.5.3.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. United Kingdom
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Country Level Analysis & Forecast
16.5.1. Germany Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Application
16.5.1.2.3. By End User
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Application
16.5.2.2.3. By End User
16.5.3. Italy Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Application
16.5.3.2.3. By End User
16.5.4. United Kingdom Market Analysis
16.5.4.1. .Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Application
16.5.4.2.3. By End User
16.5.5. Spain Market Analysis
16.5.5.1. .Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Product
16.5.5.2.2. By Application
16.5.5.2.3. By End User
16.5.6. Russia Market Analysis
16.5.6.1. .Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Product
16.5.6.2.2. By Application
16.5.6.2.3. By End User
16.5.7. BENELUX Market Analysis
16.5.7.1. .Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Product
16.5.7.2.2. By Application
16.5.7.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Country Level Analysis & Forecast
17.5.1. India Market Analysis
17.5.1.1. .Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By End User
17.5.2. Thailand Market Analysis
17.5.2.1. .Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Application
17.5.2.2.3. By End User
17.5.3. Indonesia Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Application
17.5.3.2.3. By End User
17.5.4. Malaysia Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Product
17.5.4.2.2. By Application
17.5.4.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Country Level Analysis & Forecast
18.5.1. China Market Analysis
18.5.1.1. .Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Application
18.5.1.2.3. By End User
18.5.2. Japan Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Application
18.5.2.2.3. By End User
18.5.3. South Korea Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Application
18.5.3.2.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Country Level Analysis & Forecast
19.5.1. Australia Market Analysis
19.5.1.1. .Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Application
19.5.1.2.3. By End User
19.5.2. New Zealand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Application
19.5.2.2.3. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By End User
20.5. Country Level Analysis & Forecast
20.5.1. GCC Countries Market Analysis
20.5.1.1. .Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Application
20.5.1.2.3. By End User
20.5.2. Türkiye Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Application
20.5.2.2.3. By End User
20.5.3. Northern Africa Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Application
20.5.3.2.3. By End User
20.5.4. South Africa Market Analysis
20.5.4.1. Introduction
20.5.4.2. Market Analysis and Forecast by Market Taxonomy
20.5.4.2.1. By Product
20.5.4.2.2. By Application
20.5.4.2.3. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Siemens Healthineers
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials
22.3.1.4. Sales Footprint
22.3.1.5. SWOT Analysis
22.3.1.6. Key Developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategy
22.3.1.7.2. Product Strategy
22.3.1.7.3. Channel Strategy
22.3.2. Analogic Corporation
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials
22.3.2.4. Sales Footprint
22.3.2.5. SWOT Analysis
22.3.2.6. Key Developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategy
22.3.2.7.2. Product Strategy
22.3.2.7.3. Channel Strategy
22.3.3. GE Healthcare
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials
22.3.3.4. Sales Footprint
22.3.3.5. SWOT Analysis
22.3.3.6. Key Developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategy
22.3.3.7.2. Product Strategy
22.3.3.7.3. Channel Strategy
22.3.4. Koninklijke Philips N.V.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials
22.3.4.4. Sales Footprint
22.3.4.5. SWOT Analysis
22.3.4.6. Key Developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategy
22.3.4.7.2. Product Strategy
22.3.4.7.3. Channel Strategy
22.3.5. Stryker Corporation
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials
22.3.5.4. Sales Footprint
22.3.5.5. SWOT Analysis
22.3.5.6. Key Developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategy
22.3.5.7.2. Product Strategy
22.3.5.7.3. Channel Strategy
22.3.6. Carestream Health
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials
22.3.6.4. Sales Footprint
22.3.6.5. SWOT Analysis
22.3.6.6. Key Developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategy
22.3.6.7.2. Product Strategy
22.3.6.7.3. Channel Strategy
22.3.7. Hitachi Medical Corporation
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials
22.3.7.4. Sales Footprint
22.3.7.5. SWOT Analysis
22.3.7.6. Key Developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategy
22.3.7.7.2. Product Strategy
22.3.7.7.3. Channel Strategy
22.3.8. Hologic
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials
22.3.8.4. Sales Footprint
22.3.8.5. SWOT Analysis
22.3.8.6. Key Developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategy
22.3.8.7.2. Product Strategy
22.3.8.7.3. Channel Strategy
22.3.9. United Imaging Technologies Inc.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials
22.3.9.4. Sales Footprint
22.3.9.5. SWOT Analysis
22.3.9.6. Key Developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategy
22.3.9.7.2. Product Strategy
22.3.9.7.3. Channel Strategy
22.3.10. BrainLab AG
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials
22.3.10.4. Sales Footprint
22.3.10.5. SWOT Analysis
22.3.10.6. Key Developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategy
22.3.10.7.2. Product Strategy
22.3.10.7.3. Channel Strategy
22.3.11. Karl Storz Gmbh & Co. Kg
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials
22.3.11.4. Sales Footprint
22.3.11.5. SWOT Analysis
22.3.11.6. Key Developments
22.3.11.7. Strategy Overview
22.3.11.7.1. Marketing Strategy
22.3.11.7.2. Product Strategy
22.3.11.7.3. Channel Strategy
22.3.12. Smith & Nephew Plc
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials
22.3.12.4. Sales Footprint
22.3.12.5. SWOT Analysis
22.3.12.6. Key Developments
22.3.12.7. Strategy Overview
22.3.12.7.1. Marketing Strategy
22.3.12.7.2. Product Strategy
22.3.12.7.3. Channel Strategy
22.3.13. Esaote SpA
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Key Financials
22.3.13.4. Sales Footprint
22.3.13.5. SWOT Analysis
22.3.13.6. Key Developments
22.3.13.7. Strategy Overview
22.3.13.7.1. Marketing Strategy
22.3.13.7.2. Product Strategy
22.3.13.7.3. Channel Strategy
22.3.14. Zimmer Biomet
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Key Financials
22.3.14.4. Sales Footprint
22.3.14.5. SWOT Analysis
22.3.14.6. Key Developments
22.3.14.7. Strategy Overview
22.3.14.7.1. Marketing Strategy
22.3.14.7.2. Product Strategy
22.3.14.7.3. Channel Strategy
22.3.15. Varian Medical Systems, Inc.
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Key Financials
22.3.15.4. Sales Footprint
22.3.15.5. SWOT Analysis
22.3.15.6. Key Developments
22.3.15.7. Strategy Overview
22.3.15.7.1. Marketing Strategy
22.3.15.7.2. Product Strategy
22.3.15.7.3. Channel Strategy
22.3.16. Medtronic Plc.
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Key Financials
22.3.16.4. Sales Footprint
22.3.16.5. SWOT Analysis
22.3.16.6. Key Developments
22.3.16.7. Strategy Overview
22.3.16.7.1. Marketing Strategy
22.3.16.7.2. Product Strategy
22.3.16.7.3. Channel Strategy
22.3.17. EndoMed Systems
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Key Financials
22.3.17.4. Sales Footprint
22.3.17.5. SWOT Analysis
22.3.17.6. Key Developments
22.3.17.7. Strategy Overview
22.3.17.7.1. Marketing Strategy
22.3.17.7.2. Product Strategy
22.3.17.7.3. Channel Strategy
22.3.18. Maxer Endoscopy
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Key Financials
22.3.18.4. Sales Footprint
22.3.18.5. SWOT Analysis
22.3.18.6. Key Developments
22.3.18.7. Strategy Overview
22.3.18.7.1. Marketing Strategy
22.3.18.7.2. Product Strategy
22.3.18.7.3. Channel Strategy
22.3.19. Blazejewski MEDI-TECH GmbH
22.3.19.1. Overview
22.3.19.2. Product Portfolio
22.3.19.3. Key Financials
22.3.19.4. Sales Footprint
22.3.19.5. SWOT Analysis
22.3.19.6. Key Developments
22.3.19.7. Strategy Overview
22.3.19.7.1. Marketing Strategy
22.3.19.7.2. Product Strategy
22.3.19.7.3. Channel Strategy
22.3.20. Olympus Corporation
22.3.20.1. Overview
22.3.20.2. Product Portfolio
22.3.20.3. Key Financials
22.3.20.4. Sales Footprint
22.3.20.5. SWOT Analysis
22.3.20.6. Key Developments
22.3.20.7. Strategy Overview
22.3.20.7.1. Marketing Strategy
22.3.20.7.2. Product Strategy
22.3.20.7.3. Channel Strategy
22.3.21. FUJIFILM Holdings Corporation
22.3.21.1. Overview
22.3.21.2. Product Portfolio
22.3.21.3. Key Financials
22.3.21.4. Sales Footprint
22.3.21.5. SWOT Analysis
22.3.21.6. Key Developments
22.3.21.7. Strategy Overview
22.3.21.7.1. Marketing Strategy
22.3.21.7.2. Product Strategy
22.3.21.7.3. Channel Strategy
22.3.22. Shenyang Shenda Endoscope Co., Ltd.
22.3.22.1. Overview
22.3.22.2. Product Portfolio
22.3.22.3. Key Financials
22.3.22.4. Sales Footprint
22.3.22.5. SWOT Analysis
22.3.22.6. Key Developments
22.3.22.7. Strategy Overview
22.3.22.7.1. Marketing Strategy
22.3.22.7.2. Product Strategy
22.3.22.7.3. Channel Strategy
22.3.23. Shimadzu Corporation
22.3.23.1. Overview
22.3.23.2. Product Portfolio
22.3.23.3. Key Financials
22.3.23.4. Sales Footprint
22.3.23.5. SWOT Analysis
22.3.23.6. Key Developments
22.3.23.7. Strategy Overview
22.3.23.7.1. Marketing Strategy
22.3.23.7.2. Product Strategy
22.3.23.7.3. Channel Strategy
22.3.24. Shenzhen Anke High-tech Co., Ltd.
22.3.24.1. Overview
22.3.24.2. Product Portfolio
22.3.24.3. Key Financials
22.3.24.4. Sales Footprint
22.3.24.5. SWOT Analysis
22.3.24.6. Key Developments
22.3.24.7. Strategy Overview
22.3.24.7.1. Marketing Strategy
22.3.24.7.2. Product Strategy
22.3.24.7.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Image Guided Systems Market
